Vol 7 Issue 3

CELL AND GENE THERAPY INSIGHTS

April 2021 Issue

Vol 7 Issue 3

Download PDF

Featuring

Issue Spotlight: Viral vector bioprocessing
Other articles
Webinars

SPOTLIGHT

Viral vector bioprocessing
Anindya Dasgupta
Guest Editor:
Anindya Dasgupta, Director of GMP at Expression Therapeutics

Expert Insight

Gammaretroviral and lentiviral vector manufacture: brief overview

Gammaretroviral and lentiviral vector manufacture: brief overview

Ranjita Sengupta
29 April 2021
Read

Innovator Insight

Improving upon legacy vector and plasmid bioprocess technology for tomorrow’s advanced therapies

Improving upon legacy vector and plasmid bioprocess technology for tomorrow’s advanced therapies

Henrik Ihre, PhD, Peter Guterstam, MD, Mats Lundgren, PhD
3 August 2021
Read
Facilitating gene therapy development with solutions to four capsid analytical challenges

Facilitating gene therapy development with solutions to four capsid analytical challenges

Susan Darling
29 April 2021
Read

Commentary

Making the move from antibody therapeutics to gene therapy: applicability of monoclonal antibody learnings to adeno-associated virus vector bioprocessing

Making the move from antibody therapeutics to gene therapy: applicability of monoclonal antibody learnings to adeno-associated virus vector bioprocessing

Andrew D Tustian
29 April 2021
Read
Yesterday, today and tomorrow: the evolving landscape of gene therapy manufacturing and process development

Yesterday, today and tomorrow: the evolving landscape of gene therapy manufacturing and process development

David R Knop, PhD
29 April 2021
Read

FastFacts

Cell and gene manufacturing: a case study approach to overcoming challenges

Cell and gene manufacturing: a case study approach to overcoming challenges

Sean Werner
28 April 2021
Read
Scalable, single-use technologies for purification of lentiviral vectors

Scalable, single-use technologies for purification of lentiviral vectors

Todd Sanderson
28 April 2021
Read
The Corning® Ascent™ Fixed Bed Reactor (FBR) System: Designed for high yield, scalable viral vector production & other applications for cell & gene therapies.

The Corning® Ascent™ Fixed Bed Reactor (FBR) System: Designed for high yield, scalable viral vector production & other applications for cell & gene therapies.

Zara Melkoumian
28 April 2021
Read
Efficient and scalable purification of mRNA using affinity chromatography

Efficient and scalable purification of mRNA using affinity chromatography

Zoltan Gulyas
27 April 2021
Read
Simplifying AAV protein analytics with Maurice

Simplifying AAV protein analytics with Maurice

Chris Heger PhD
27 April 2021
Read
The EuLV system: lentiviral vector production based on stable producer cell lines

The EuLV system: lentiviral vector production based on stable producer cell lines

Roy Bin Liu
20 April 2021
Read

Infographic

Manufacturing and analytics for lentivirus and AAV vectors: a visual and audio guide

Manufacturing and analytics for lentivirus and AAV vectors: a visual and audio guide

20 August 2021
Read

Podcast

Improving AAV vector manufacture: a question of scale

Improving AAV vector manufacture: a question of scale

Silke Wissing, Juliana Coronel
29 April 2021
Listen

Interview

Current and future perspectives on lentiviral vector bioprocess and bioanalytical tools

Current and future perspectives on lentiviral vector bioprocess and bioanalytical tools

Paul Carter
4 May 2021
Read
Improving AAV vector manufacture: a question of scale

Improving AAV vector manufacture: a question of scale

S Wissing, J Coronel, J Wölfel et al.
29 April 2021
Read
Keys to success for in-house lentiviral vector tech transfer and manufacture

Keys to success for in-house lentiviral vector tech transfer and manufacture

Nicole Nuñez, Liam Powers
29 April 2021
Read
How fixed bed bioreactors are changing the game for adherent cell culture-based vector production

How fixed bed bioreactors are changing the game for adherent cell culture-based vector production

Todd Upton, Vasiliy Goral
29 April 2021
Read

Journal articles

FastFacts

A demonstration of the Cocoon® platform: a bespoke solution to minimize manual touchpoints in cell therapy manufacturing

A demonstration of the Cocoon® platform: a bespoke solution to minimize manual touchpoints in cell therapy manufacturing

Joseph O’Connor
20 April 2021
Read

Perspective

Current status and future perspective of gene therapy products in Japan

Current status and future perspective of gene therapy products in Japan

Y Maruyama, A Sakurai, M Kasai et al.
11 March 2021
Read

Interview

Stem cell therapy: current obstacles and innovations

Stem cell therapy: current obstacles and innovations

Joshua Hare
22 March 2021
Read
Examining Health Canada’s agile new approach to regulating Advanced Therapeutic Products

Examining Health Canada’s agile new approach to regulating Advanced Therapeutic Products

Elizabeth Toller, Liz Anne Gillham-Eisen, Nadine Kolas
19 March 2021
Read

Shelfie

On my bookshelf...

On my bookshelf...

Qasim Rafiq
16 March 2021
Read
On my bookshelf...

On my bookshelf...

Robert Deans
3 March 2021
Read

Webinars